Utama › Kanser Pundi Kencing Bukan Invasif Otot
Kajian klinikal Kanser Pundi Kencing Bukan Invasif Otot sedang mengambil peserta di AS
33 kajian untuk Kanser Pundi Kencing Bukan Invasif Otot sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- New York City, NY10 kajian
- Columbus, OH10 kajian
- Dallas, TX10 kajian
- Edison, NJ9 kajian
- Myrtle Beach, SC9 kajian
- Nashville, TN8 kajian
- Syracuse, NY8 kajian
- Baltimore, MD8 kajian
- Philadelphia, PA7 kajian
- Houston, TX7 kajian
- Birmingham, AL7 kajian
- Indianapolis, IN7 kajian
- Atlanta, GA7 kajian
- Austin, TX6 kajian
- Los Angeles, CA6 kajian
- San Antonio, TX6 kajian
- Little Rock, AR6 kajian
- Boston, MA6 kajian
- St. Louis, MO6 kajian
- Chicago, IL6 kajian
- Bakersfield, CA5 kajian
- Cicero, IL5 kajian
- Memphis, TN5 kajian
- Tampa, FL5 kajian
- Durham, NC5 kajian
- East Norwalk, CT4 kajian
- Greenburgh, NY4 kajian
- Queens, NY4 kajian
- Staten Island, NY4 kajian
- Seattle, WA4 kajian
- Pittsburgh, PA4 kajian
- Jacksonville, FL4 kajian
- Lakewood, CO4 kajian
- Kansas City, KS4 kajian
- Washington, DC4 kajian
- New Rochelle, NY3 kajian
- Lafayette, LA3 kajian
- Cincinnati, OH3 kajian
- Rochester, MN3 kajian
- Phoenix, AZ3 kajian
Mengikut negeri
- Alabama7 kajian
- Arizona9 kajian
- Arkansas6 kajian
- California15 kajian
- Colorado5 kajian
- Florida15 kajian
- Georgia7 kajian
- Illinois11 kajian
- Indiana8 kajian
- Iowa3 kajian
- Kansas4 kajian
- Louisiana5 kajian
- Maryland8 kajian
- Massachusetts10 kajian
- Michigan7 kajian
- Minnesota4 kajian
- Missouri7 kajian
- New Jersey9 kajian
- New York16 kajian
- North Carolina6 kajian
- Ohio13 kajian
- Oregon3 kajian
- Pennsylvania9 kajian
- South Carolina12 kajian
- Tennessee10 kajian
- Texas15 kajian
- Virginia6 kajian
- Washington5 kajian
- Wilayah Columbia4 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07309445A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06733363Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT05796375A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06503614Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07144319A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT06637423Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05951179Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 99 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05825950Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT07480356A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
Mengambil pesertaFasa 3
Umur 21 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT06929286FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05614739A Phase I Intravesical PPM Therapy for NMIBC
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05519241Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT05126472Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC)
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Ogo 2026 · NCT07763197LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT04752722Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT07225127Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT07673016A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Mei 2026 · NCT05710848Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC
Mengambil pesertaFasa 2
Umur 18 hingga 99 · Semua jantina · Dikemas kini 17 Apr 2026 · NCT07322263In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Mac 2026 · NCT06704191Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.